{"id":2623,"date":"2026-02-23T17:25:16","date_gmt":"2026-02-23T17:25:16","guid":{"rendered":"https:\/\/99puritypeptides.com\/?p=2623"},"modified":"2026-03-31T05:15:54","modified_gmt":"2026-03-31T05:15:54","slug":"what-are-research-peptides-complete-laboratory-guide-2026","status":"publish","type":"post","link":"https:\/\/99puritypeptides.com\/es\/what-are-research-peptides-complete-laboratory-guide-2026\/","title":{"rendered":"\u00bfQu\u00e9 Son La Investigaci\u00f3n De Los P\u00e9ptidos? Una Gu\u00eda Completa para Estudios de Laboratorio (2026)"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg&#8221; parallax=&#8221;on&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; min_height=&#8221;500px&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; locked=&#8221;off&#8221; alt=&#8221;Scientist in gloves examining a small vial of liquid in a laboratory with test tubes, microscope, and laptop in the background.&#8221; title_text=&#8221;female-researcher-laboratory-with-test-tubes-vaccine-bottle&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|desktop&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#08171a&#8221; custom_margin=&#8221;||||true|false&#8221; custom_margin_tablet=&#8221;0px||0px||true|false&#8221; custom_margin_phone=&#8221;0px||0px||true|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||||true|false&#8221; custom_padding_tablet=&#8221;0px||0px||true|false&#8221; custom_padding_phone=&#8221;0px||0px||true|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_row custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;||50px||false|false&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;&#8211;et_global_body_font|600|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>What Are Research Peptides? A Complete Guide for Laboratory Studies (2026)<\/h1>\n<p><span style=\"font-weight: 400;\">Research peptides are synthetic compounds used exclusively in scientific and analytical laboratory environments. If you are asking <\/span><b>what are research peptides<\/b><span style=\"font-weight: 400;\">, this guide explains how synthetic research peptides are produced, classified, tested, and regulated.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In modern laboratory studies, <\/span><b>research peptides<\/b><span style=\"font-weight: 400;\"> are carefully synthesized amino acid sequences used to study cell signaling pathways, peptide structure and function research, metabolic research peptides, and molecular interaction systems. These compounds are supplied as <\/span><b>laboratory grade peptides<\/b><span style=\"font-weight: 400;\"> and designated strictly for research use only.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This article provides a complete, compliance-focused overview of research peptides explained for laboratory professionals in 2026.<\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;&#8211;et_global_body_font|600|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>What Are Research Peptides?<\/h2>\n<p><span style=\"font-weight: 400;\">Research peptides are short chains of amino acids synthetically produced for controlled laboratory experiments. Unlike pharmaceutical drugs, <\/span><b>synthetic research peptides<\/b><span style=\"font-weight: 400;\"> are not approved for therapeutic use and are classified strictly for scientific investigation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In peptide structure and function research, peptides are studied to analyze:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cell signaling peptides research<\/span><span style=\"font-weight: 400;\"><br \/><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Metabolic research peptides<\/span><span style=\"font-weight: 400;\"><br \/><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Receptor-binding interactions<\/span><span style=\"font-weight: 400;\"><br \/><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Molecular pathway modeling<\/span><span style=\"font-weight: 400;\"><br \/><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Protein interaction systems<\/span><\/li>\n<\/ul>\n<p><a href=\"https:\/\/99puritypeptides.com\/shop\/\"><b>Laboratory grade peptides<\/b><\/a><span style=\"font-weight: 400;\"> are produced under controlled synthesis conditions and verified through analytical testing to ensure structural accuracy and purity.<\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;&#8211;et_global_body_font|600|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>How Are Synthetic Research Peptides Produced?<\/h2>\n<p><span style=\"font-weight: 400;\">The process of <\/span><b>synthetic peptide production<\/b><span style=\"font-weight: 400;\"> typically involves solid-phase peptide synthesis (SPPS), a controlled laboratory method that builds amino acid sequences step-by-step.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The peptide synthesis process generally includes:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Sequential amino acid coupling<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cleavage from solid support<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Purification via chromatography<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Analytical confirmation testing<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Following production, <\/span><a href=\"https:\/\/99puritypeptides.com\/medical-disclaimer\/\"><b>peptide analytical testing<\/b><\/a><span style=\"font-weight: 400;\"> verifies molecular identity and purity levels. Analytical techniques often include:<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">High-performance liquid chromatography (HPLC)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mass spectrometry (MS)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Structural confirmation assays.<\/span><span style=\"font-weight: 400;\"><\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">This ensures that laboratory grade peptides meet predefined analytical specifications before distribution.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;&#8211;et_global_body_font|600|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; header_3_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_3_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>What Does \u201cResearch Use Only\u201d Mean?<\/h2>\n<p><span style=\"font-weight: 400;\">\u201cResearch use only\u201d indicates that the product is intended strictly for laboratory and analytical research purposes. <\/span><a href=\"https:\/\/99puritypeptides.com\/faq\/\"><b>Research use only peptides<\/b><\/a><span style=\"font-weight: 400;\"> are not approved for:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Human consumption<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Veterinary use<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Diagnosis or treatment<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Injection or ingestion<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">This classification ensures clear separation between experimental materials and regulated pharmaceutical products.<\/span><\/p>\n<h3>How Are Research Peptides Tested for Purity?<\/h3>\n<p><span style=\"font-weight: 400;\">High-quality <\/span><b>peptides with COA (Certificate of Analysis)<\/b><span style=\"font-weight: 400;\"> are accompanied by documentation verifying purity and identity.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A <\/span><b>Certificate of Analysis<\/b><span style=\"font-weight: 400;\"> typically includes:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Batch number<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Purity percentage<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Analytical method summary<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Chromatography results<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Researchers seeking <\/span><b>third party tested peptides<\/b><span style=\"font-weight: 400;\"> should confirm whether independent laboratory verification has been performed.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Purity testing commonly includes:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">HPLC peptide testing<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mass spectrometry validation<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stability testing<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Proper documentation ensures reproducibility and analytical confidence in laboratory research.<\/span><\/p>\n<h3>Are Research Peptides Legal in the USA?<\/h3>\n<p><span style=\"font-weight: 400;\">Research peptides may be legally purchased when intended strictly for laboratory research use. However, regulatory oversight depends on classification and intended application.<\/span><\/p>\n<p>Are peptides FDA approved?<\/p>\n<p><span style=\"font-weight: 400;\">Most research peptides are <\/span><b>not FDA approved<\/b><span style=\"font-weight: 400;\"> as drugs. FDA approval applies to pharmaceutical products, not to research-use-only laboratory materials.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Purchasers are responsible for complying with applicable federal, state, and institutional regulations when acquiring synthetic research peptides.<\/span><\/p>\n<h3>Peptide Classification in Research<\/h3>\n<p><span style=\"font-weight: 400;\">In laboratory settings, <\/span><b>peptide classification in research<\/b><span style=\"font-weight: 400;\"> separates compounds based on intended use and regulatory category.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Research peptides typically fall into:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Synthetic research peptides<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Analytical-grade peptides<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Laboratory grade peptides<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Investigational compounds<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Classification ensures proper labeling, documentation, and distribution practices.<\/span><\/p>\n<h3>How to Choose a Reliable Peptide Supplier<\/h3>\n<p><span style=\"font-weight: 400;\">When evaluating <\/span><b>how to choose a peptide supplier<\/b><span style=\"font-weight: 400;\">, researchers should consider:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Availability of peptides with COA<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Third party tested peptides<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Transparent documentation practices<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Consistent purity verification<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Clear research-use-only designation<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">A reputable <\/span><a href=\"https:\/\/99puritypeptides.com\/\"><b>peptide supplier USA<\/b><\/a><span style=\"font-weight: 400;\"> should prioritize analytical verification and regulatory clarity.<\/span><\/p>\n<h3>The Role of Research Peptides in Modern Laboratory Studies<\/h3>\n<p><span style=\"font-weight: 400;\">Research peptides continue to play an important role in:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cell signaling peptides research<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Metabolic research peptides<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Receptor pathway modeling<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Molecular interaction studies<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Synthetic biology research<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Because of their modular structure, peptides provide researchers with controlled tools to investigate biological complexity under defined laboratory conditions.<\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;&#8211;et_global_body_font|600|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_font=&#8221;&#8211;et_global_body_font|700|||||||&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Commercial Bridge<\/h2>\n<p><span style=\"font-weight: 400;\">For laboratories requiring <\/span><a href=\"https:\/\/99puritypeptides.com\/shop\/\"><b>high purity research peptides<\/b><\/a><span style=\"font-weight: 400;\">, selecting a supplier that provides peptides with COA, structured analytical verification, and compliance transparency is essential.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#0a0202&#8243; background_enable_image=&#8221;off&#8221; background_position=&#8221;center_right&#8221; custom_padding=&#8221;||||true|false&#8221; custom_padding_tablet=&#8221;||||false|false&#8221; custom_padding_phone=&#8221;||||true|false&#8221; custom_css_free_form=&#8221;@media (max-width: 1024px) and (min-width: 981px){||  selector {||    padding: 60px 0px 70px !important; ||}||}&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_heading title=&#8221;Questions&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h2&#8243; title_font=&#8221;Montserrat|700|||||||&#8221; title_text_align=&#8221;center&#8221; title_text_color=&#8221;#ffffff&#8221; title_font_size=&#8221;32px&#8221; title_line_height=&#8221;42px&#8221; custom_margin=&#8221;0px||0px||true|false&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_heading][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;#fafafa&#8221; text_line_height=&#8221;26px&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;0px||0px||true|false&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjI2NDgyODQ3OSwiZGF0YVR5cGUiOiJzY2VuZSJ9Cg==(\/figmeta)--&gt;\"><\/span><span data-buffer=\"&lt;!--(figma)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(\/figma)--&gt;\"><\/span><span>Common questions about research peptides, ordering, and lab standards<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; width=&#8221;60%&#8221; width_tablet=&#8221;90%&#8221; width_phone=&#8221;90%&#8221; width_last_edited=&#8221;on|tablet&#8221; custom_margin=&#8221;30px||||false|false&#8221; custom_margin_tablet=&#8221;20px||||false|false&#8221; custom_margin_phone=&#8221;20px||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding_tablet=&#8221;0px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_accordion toggle_icon=&#8221;&#x4c;||divi||400&#8243; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; border_radii=&#8221;on|8px|8px|8px|8px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_accordion_item title=&#8221;What does retatrutide do to cancer cells in preclinical studies?&#8221; open=&#8221;on&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>Preclinical research from 2025 shows retatrutide reduces tumor engraftment, delays tumor onset, and significantly decreases tumor volume in mouse models. In pancreatic cancer models, retatrutide produced a 14-fold reduction in tumor volume, while lung cancer models showed a 17-fold reduction. The compound also appears to reprogram the immune system and tumor microenvironment, with effects persisting even after treatment withdrawal.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;How does retatrutide compare to semaglutide for cancer research?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>In the Marathe et al. (2025) study, retatrutide showed significantly stronger anti-tumor effects than semaglutide in obesity-driven cancer models. While both compounds produced weight loss, retatrutide achieved a 14-fold tumor reduction in pancreatic cancer versus only 4-fold with semaglutide. Retatrutide also uniquely reduced visceral fat deposits and produced durable immune reprogramming that semaglutide did not replicate.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;What cancer types has retatrutide been studied in?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>Preclinical retatrutide cancer research has focused on pancreatic ductal adenocarcinoma, lung adenocarcinoma, and triple-negative breast cancer (TNBC). The Marathe et al. study (2025) examined pancreatic and lung cancer models, while the Cui et al. study (2025) investigated TNBC, specifically looking at chemotherapy resistance mechanisms.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;Is retatrutide approved for cancer treatment?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>No. Retatrutide is currently in Phase 3 clinical trials for obesity and metabolic conditions, not cancer treatment. All cancer-related findings are from preclinical mouse studies only. Retatrutide is not approved for human use in any oncological application and is available only as a research chemical for laboratory studies.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;Why is retatrutide being studied in cancer research?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>Researchers are studying retatrutide because obesity creates metabolic conditions that support tumor growth\u2014including chronic inflammation, elevated insulin, and immunosuppression. As a triple-receptor agonist (GLP-1, GIP, and glucagon), retatrutide alters the metabolic environment more comprehensively than single-agonist drugs, making it valuable for studying how metabolic changes affect cancer cell behavior and the tumor microenvironment.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;How does retatrutide affect chemotherapy resistance?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>According to the Cui et al. (2025) study, retatrutide disrupts a molecular pathway that drives chemotherapy resistance in triple-negative breast cancer. It suppresses O-GlcNAcylation of the YAP transcription factor, which enhances YAP degradation and sensitizes cancer cells to chemotherapy. In obese mouse models, combining retatrutide with gemcitabine overcame gemcitabine resistance and significantly reduced tumor growth.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;What makes retatrutide different from other GLP-1 agonists in cancer studies?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>Retatrutide is unique because it targets three receptors (GLP-1, GIP, and glucagon) rather than one or two. This triple-receptor agonism appears to produce metabolic and immune effects that single-agonist compounds like semaglutide don&#8217;t fully replicate. The additional glucagon receptor (GCGR) activation may contribute to the more pronounced anti-tumor effects observed in preclinical models.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;What were the main findings of the 2025 retatrutide cancer studies?&#8221; open_toggle_text_color=&#8221;#fafafa&#8221; open_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; closed_toggle_text_color=&#8221;#fafafa&#8221; closed_toggle_background_color=&#8221;RGBA(255,255,255,0)&#8221; icon_color=&#8221;#fafafa&#8221; toggle_icon=&#8221;&#x4c;||divi||400&#8243; use_icon_font_size=&#8221;on&#8221; icon_font_size=&#8221;20px&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;Montserrat||||||||&#8221; body_text_color=&#8221;#fafafa&#8221; body_font_size=&#8221;14px&#8221; body_line_height=&#8221;24px&#8221; custom_padding=&#8221;25px||25px||true|false&#8221; global_colors_info=&#8221;{}&#8221; toggle_text_color=&#8221;#fafafa&#8221; toggle_level=&#8221;h3&#8243; toggle_font=&#8221;Montserrat|700|||||||&#8221; toggle_font_size=&#8221;18px&#8221; toggle_line_height=&#8221;100%&#8221; closed_toggle_font=&#8221;Montserrat|700|||||||&#8221; closed_toggle_font_size=&#8221;18px&#8221; closed_toggle_line_height=&#8221;100%&#8221; open=&#8221;off&#8221;]<\/p>\n<p><span data-metadata=\"&lt;!--(figmeta)eyJmaWxlS2V5IjoieTVpb1k4OHM4dWNnQ1JjNUQ2R01VViIsInBhc3RlSUQiOjIwNjY0MjAzMDUsImRhdGFUeXBlIjoic2NlbmUifQo=(\/figmeta)--&gt;\"><\/span>Two major studies published in 2025 found:<\/p>\n<ol>\n<li>Marathe et al. reported 14-17 fold tumor volume reductions in pancreatic and lung cancer models with immune reprogramming effects.<\/li>\n<li>Cui et al. showed retatrutide overcomes chemotherapy resistance in triple-negative breast cancer by disrupting YAP stabilization. <br \/>Both studies were conducted in obese mouse models and showed effects beyond simple weight loss.<\/li>\n<\/ol>\n<p>[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;40px||||false|false&#8221; custom_padding=&#8221;||40px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_heading title=&#8221;Still have questions?&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h2&#8243; title_font=&#8221;Montserrat|700|||||||&#8221; title_text_align=&#8221;center&#8221; title_text_color=&#8221;#ffffff&#8221; title_font_size=&#8221;32px&#8221; title_line_height=&#8221;42px&#8221; custom_margin=&#8221;0px||0px||true|false&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_heading][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;#fafafa&#8221; text_line_height=&#8221;26px&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;0px||0px||true|false&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]Reach out to our team anytime[\/et_pb_text][et_pb_button button_text=&#8221;contact&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;14px&#8221; button_text_color=&#8221;#ffffff&#8221; button_bg_color=&#8221;#1e5d68&#8243; button_border_radius=&#8221;8px&#8221; button_font=&#8221;&#8211;et_global_heading_font|600||on|||||&#8221; button_use_icon=&#8221;off&#8221; custom_margin=&#8221;10px||||false|false&#8221; custom_padding=&#8221;16px||16px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>What Are Research Peptides? A Complete Guide for Laboratory Studies (2026) Research peptides are synthetic compounds used exclusively in scientific and analytical laboratory environments. If you are asking what are research peptides, this guide explains how synthetic research peptides are produced, classified, tested, and regulated. In modern laboratory studies, research peptides are carefully synthesized amino [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2626,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"2880","footnotes":""},"categories":[75,70],"tags":[],"class_list":["post-2623","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-use-classification","category-semaglutide"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What Are Research Peptides? Complete Laboratory Guide (2026)<\/title>\n<meta name=\"description\" content=\"What are research peptides? Learn how synthetic research peptides are produced, tested for purity, and classified for laboratory use.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/99puritypeptides.com\/es\/what-are-research-peptides-complete-laboratory-guide-2026\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What Are Research Peptides? Complete Laboratory Guide (2026)\" \/>\n<meta property=\"og:description\" content=\"What are research peptides? Learn how synthetic research peptides are produced, tested for purity, and classified for laboratory use.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/99puritypeptides.com\/es\/what-are-research-peptides-complete-laboratory-guide-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"99 Purity Peptides\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-23T17:25:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-31T05:15:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1829\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tech-Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tech-Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What Are Research Peptides? Complete Laboratory Guide (2026)","description":"What are research peptides? Learn how synthetic research peptides are produced, tested for purity, and classified for laboratory use.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/99puritypeptides.com\/es\/what-are-research-peptides-complete-laboratory-guide-2026\/","og_locale":"es_MX","og_type":"article","og_title":"What Are Research Peptides? Complete Laboratory Guide (2026)","og_description":"What are research peptides? Learn how synthetic research peptides are produced, tested for purity, and classified for laboratory use.","og_url":"https:\/\/99puritypeptides.com\/es\/what-are-research-peptides-complete-laboratory-guide-2026\/","og_site_name":"99 Purity Peptides","article_published_time":"2026-02-23T17:25:16+00:00","article_modified_time":"2026-03-31T05:15:54+00:00","og_image":[{"width":2560,"height":1829,"url":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg","type":"image\/jpeg"}],"author":"Tech-Admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Tech-Admin","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#article","isPartOf":{"@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/"},"author":{"name":"Tech-Admin","@id":"https:\/\/99puritypeptides.com\/#\/schema\/person\/e55552079f2f37ec910151ea4b2951dd"},"headline":"What Are Research Peptides? A Complete Guide for Laboratory Studies (2026)","datePublished":"2026-02-23T17:25:16+00:00","dateModified":"2026-03-31T05:15:54+00:00","mainEntityOfPage":{"@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/"},"wordCount":2912,"publisher":{"@id":"https:\/\/99puritypeptides.com\/#organization"},"image":{"@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg","articleSection":["Product Use &amp; Classification","Semaglutide"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/","url":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/","name":"What Are Research Peptides? Complete Laboratory Guide (2026)","isPartOf":{"@id":"https:\/\/99puritypeptides.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#primaryimage"},"image":{"@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg","datePublished":"2026-02-23T17:25:16+00:00","dateModified":"2026-03-31T05:15:54+00:00","description":"What are research peptides? Learn how synthetic research peptides are produced, tested for purity, and classified for laboratory use.","breadcrumb":{"@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#primaryimage","url":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg","contentUrl":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2026\/02\/female-researcher-laboratory-with-test-tubes-vaccine-bottle-scaled.jpg","width":2560,"height":1829,"caption":"Scientist in gloves examining a small vial of liquid in a laboratory with test tubes, microscope, and laptop in the background."},{"@type":"BreadcrumbList","@id":"https:\/\/99puritypeptides.com\/what-are-research-peptides-complete-laboratory-guide-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/99puritypeptides.com\/"},{"@type":"ListItem","position":2,"name":"What Are Research Peptides? A Complete Guide for Laboratory Studies (2026)"}]},{"@type":"WebSite","@id":"https:\/\/99puritypeptides.com\/#website","url":"https:\/\/99puritypeptides.com\/","name":"99 Purity Peptides","description":"","publisher":{"@id":"https:\/\/99puritypeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/99puritypeptides.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/99puritypeptides.com\/#organization","name":"99 Purity Peptides","url":"https:\/\/99puritypeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/99puritypeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2025\/12\/99-Purity-Peptides-logo.png","contentUrl":"https:\/\/99puritypeptides.com\/wp-content\/uploads\/2025\/12\/99-Purity-Peptides-logo.png","width":239,"height":100,"caption":"99 Purity Peptides"},"image":{"@id":"https:\/\/99puritypeptides.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/99puritypeptides.com\/#\/schema\/person\/e55552079f2f37ec910151ea4b2951dd","name":"Tech-Admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/40f1be3f1f5d04abecbd756bd94581cbf8ad889cae584be7a6fd1e9f8eacdd77?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/40f1be3f1f5d04abecbd756bd94581cbf8ad889cae584be7a6fd1e9f8eacdd77?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40f1be3f1f5d04abecbd756bd94581cbf8ad889cae584be7a6fd1e9f8eacdd77?s=96&d=mm&r=g","caption":"Tech-Admin"},"sameAs":["https:\/\/99puritypeptides.com"]}]}},"_links":{"self":[{"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/posts\/2623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/comments?post=2623"}],"version-history":[{"count":0,"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/posts\/2623\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/media\/2626"}],"wp:attachment":[{"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/media?parent=2623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/categories?post=2623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/99puritypeptides.com\/es\/wp-json\/wp\/v2\/tags?post=2623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}